A new trading day began on Monday, with Immix Biopharma Inc (NASDAQ: IMMX) stock price up 8.98% from the previous day of trading, before settling in for the closing price of $2.06. IMMX’s price has ranged from $1.26 to $3.20 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -43.61%. Meanwhile, its annual earnings per share averaged 5.59%. With a float of $16.20 million, this company’s outstanding shares have now reached $28.41 million.
Immix Biopharma Inc (IMMX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immix Biopharma Inc is 43.82%, while institutional ownership is 8.28%. The most recent insider transaction that took place on Sep 17 ’25, was worth 5,050. In this transaction CEO and Chairman of this company bought 2,500 shares at a rate of $2.02, taking the stock ownership to the 1,140,937 shares. Before that another transaction happened on Sep 16 ’25, when Company’s CFO bought 2,600 for $1.97, making the entire transaction worth $5,122. This insider now owns 290,659 shares in total.
Immix Biopharma Inc (IMMX) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.24 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.59% per share during the next fiscal year.
Immix Biopharma Inc (NASDAQ: IMMX) Trading Performance Indicators
Here are Immix Biopharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.76 in one year’s time.
Technical Analysis of Immix Biopharma Inc (IMMX)
Looking closely at Immix Biopharma Inc (NASDAQ: IMMX), its last 5-days average volume was 0.28 million, which is a jump from its year-to-date volume of 0.17 million. As of the previous 9 days, the stock’s Stochastic %D was 43.57%.
During the past 100 days, Immix Biopharma Inc’s (IMMX) raw stochastic average was set at 28.20%, which indicates a significant decrease from 69.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.15 in the past 14 days, which was lower than the 0.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.26, while its 200-day Moving Average is $2.11. However, in the short run, Immix Biopharma Inc’s stock first resistance to watch stands at $2.42. Second resistance stands at $2.59. The third major resistance level sits at $2.80. If the price goes on to break the first support level at $2.03, it is likely to go to the next support level at $1.82. Now, if the price goes above the second support level, the third support stands at $1.65.
Immix Biopharma Inc (NASDAQ: IMMX) Key Stats
With a market capitalization of 64.73 million, the company has a total of 28,834K Shares Outstanding. Currently, annual sales are 0 K while annual income is -21,610 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,620 K.
